Caution: Ramipril Users Must Heed New Blood Pressure Medication Alert

A critical alert has been issued regarding the use of Ramipril, a commonly prescribed blood pressure medication. Crescent Pharma Limited has announced a precautionary recall of Ramipril 5 mg Capsules in the UK due to a significant packaging error. This recall could potentially place patients at risk.

Details of the Recall

The recall affects the batch number GR164099. This specific batch erroneously contains blister packs of Amlodipine 5 mg Tablets instead of Ramipril. Patients are urged to inspect the medication they have received to verify alignment between the carton’s labeling and the blister strips found inside.

Instructions for Patients

• Check the carton of your Ramipril medication.
• Ensure the blister strips correctly match the medication name on the packaging.
• If there’s a discrepancy and you discover Amlodipine instead of Ramipril, promptly contact your pharmacy.

Health Implications

Ramipril plays a vital role in managing high blood pressure (hypertension) and heart failure. It is also commonly prescribed following a heart attack. This medication assists in preventing future strokes, heart attacks, and kidney issues. Furthermore, it enhances survival rates for patients with heart conditions.

Shareen Doak, Deputy Director, Benefit-Risk Evaluation at the MHRA, emphasized the importance of following safety measures. “If you’ve received this affected batch, please take the accompanying leaflet and any remaining tablets to your pharmacy or GP practice,” she advised. “If you’ve inadvertently consumed Amlodipine, rest assured that the risk to your health is minimal.”

Potential Effects of Amlodipine

Even though both Ramipril and Amlodipine are utilized to control blood pressure, it is essential to understand that switching medications can lead to different side effects. If patients take Amlodipine unknowingly, they may experience lower-than-normal blood pressure levels and dizziness.

Advice for Patients with Diabetes

Those living with diabetes should monitor their blood sugar levels frequently, particularly during the initial weeks of taking Ramipril. This medication has the potential to lower blood sugar, necessitating closer observation.

Patients are encouraged to stay updated and follow all health recommendations related to this recall. For more information, visit Filmogaz.com.